Boehringer Ingelheim
Large privately held pharmaceutical company with major cardiometabolic and respiratory franchises.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
Selected patent records
nintedanib esylate · Expires 2025-10-01
US 8883805empagliflozin · Expires 2025-11-26
US 10154990nintedanib esylate · Expires 2026-01-08
US 8022082tiotropium bromide · Expires 2026-01-19
US 6762180*PEDnintedanib esylate · Expires 2026-04-01
US 8883805*PEDempagliflozin · Expires 2026-05-26
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/boehringer-ingelheim/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.